Skip to main content

Table 2 Median age and range at diagnosis of Lynch syndrome associated cancer

From: Cancer risk in MLH1, MSH2 and MSH6 mutation carriers; different risk profiles may influence clinical management

  MLH1 MSH2 MSH6
Colorectal cancer 47 (25-79) 44 (20-82) 53 (32-84)
Endometrial cancer 51 (46-54) 46 (36-55) 56 (47-67)
Ovarian carcinoma 52 (52-52) 47 (45-48) 49 (35-51)
Small bowel cancer 54 (54-54) 36 (23-49) -
Transitional cell carcinoma - 58 (32-59) -